Back

12-month safety and effectiveness of a dual energy focal pulsed field ablation system to treat paroxysmal atrial fibrillation: results from the FlexPulse IDE study

29 August 2026 (14:30 - 14:45)
Organised by: Logo
Congress Presentation Part of: The evolution of atrial fibrillation ablation: energy, mapping and precision patient selection Rhythm Control, Catheter Ablation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ayman Hussein

Cleveland Clinic, Cleveland (United States of America)

4 More presentations in this session

Presentation thumbnail
Hybrid Versus Catheter Ablation for Persistent Atrial Fibrillation and Heart Failure: The HALT AF Randomised Trial
Doctor O. Ahmed (London, GB)
Presentation thumbnail
Pulmonary Vein Isolation with Pulsed Field Ablation with versus without Posterior Wall Ablation in Patients with Symptomatic Persistent Atrial Fibrillation
Professor L. Roten (Bern, CH)
Presentation thumbnail
Pulsed-Field Ablation With/Without Electrogram Mapping of Key Substrates for Non-paroxysmal Atrial Fibrillation: A Prospective Multicenter Randomized Study (PEAK-AF Study)
Doctor K. Li (Shanghai, CN)
Presentation thumbnail
AI-Guided Shared Decision-Making for Optimizing Patient Selection in Atrial Fibrillation Catheter Ablation: A Randomized Clinical Trial (AI-PAFA Trial)
Doctor T. Hwang (Seoul, KR)

Access the full session

Session thumbnail
The evolution of atrial fibrillation ablation: energy, mapping and precision patient selection

The Event

Event poster

ESC Congress 2026

29 August 2026 14:30 CET
You may be interested in
thumbnail
Webinar
Pulsed field ablation in the treatment of arrhythmias; faster, stronger and safer?
29 July 2025
thumbnail
Congress Presentation
Acute procedural safety of dual-energy ablation for atrial fibrillation:a systematic review and meta-analysis
13 April 2026
thumbnail
Congress Session
Ablation strategies beyond pulmonary vein isolation in persistent atrial fibrillation
30 March 2025
thumbnail
Congress Presentation
Acute safety and performance outcomes from the inspIRE trial using a novel pulsed field ablation system for the treatment of paroxysmal atrial fibrillation
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources